Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative Announces Clinical Trial Contract With Second Site For Phase 2 Clinical Trial To Treat CLDD

June 22 (Reuters) - BioRestorative Therapies Inc  BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES CLINICAL TRIAL CONTRACT
WITH
SECOND SITE FOR THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT
CHRONIC LUMBAR DISC DISEASE (CLDD)

Source text for Eikon:  ID:nGNX3n1fT6 
Further company coverage:  BRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biorestorative Therapies

See all news